MedTrace Logo

EXCEL Clinical Trial (Universal Registry)

NCT01205789 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2012-12-04

No results posted yet for this study

Summary

The purpose of the Universal Registry is to assess the proportion and reasons for which subjects with angiographically significant ULMCA disease requiring revascularization during the time course of this study are not randomized; to compare the baseline characteristics of subjects; and to assess the variability in randomization eligibility and treatment patterns.

Conditions

  • Chronic Coronary Occlusion
  • Left Main Coronary Artery Disease
  • Stent Thrombosis
  • Vascular Disease
  • Myocardial Ischemia
  • Coronary Artery Stenosis
  • Coronary Disease
  • Coronary Artery Disease
  • Coronary Restenosis

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Gregg W Stone, MD · Columbia University

  • Patrick W Serruys, MD · Erasmus Medical Center

  • Joseph Sabik, MD · Cleveland Clinical Main Campus

  • A. Pieter Kappetein, MD · Erasmus Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01205789 on ClinicalTrials.gov